Mei-Yin Polley to Biomarkers
This is a "connection" page, showing publications Mei-Yin Polley has written about Biomarkers.
Connection Strength
0.977
-
Statistical Considerations in the Evaluation of Continuous Biomarkers. J Nucl Med. 2021 05 10; 62(5):605-611.
Score: 0.496
-
Development of omics-based clinical tests for prognosis and therapy selection: the challenge of achieving statistical robustness and clinical utility. Clin Trials. 2013 Oct; 10(5):653-65.
Score: 0.296
-
Two-stage adaptive cutoff design for building and validating a prognostic biomarker signature. Stat Med. 2014 Dec 20; 33(29):5097-110.
Score: 0.080
-
Randomized phase II trial designs with biomarkers. J Clin Oncol. 2012 Sep 10; 30(26):3304-9.
Score: 0.069
-
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nat Med. 2023 Dec; 29(12):3067-3076.
Score: 0.037